glp-1 receptor agonists blindness risk Mapping the effectiveness and risks of Zepbound Blindness Lawsuit [2026 Update]

A randomized controlled trial by Mann J et al

Implants Implantable SC implants and osmotic pumps represent advanced technologies for sustained drug delivery, leveraging distinct mechanisms to achieve long-term therapeutic efficacy

This is where the expert discovery phase currently underway in the MDL becomes so important

While GIP has lost most of its insulinotropic activity in patients with T2D, GLP-1 has retained enough of its insulinotropic activity to stimulate insulin secretory responses even in patients with T2D [55]

In a number of studies, GLP-1R agonists such as liraglutide, exenatide and lixisenatide can reduce neuroinflammation in AD models, thereby improving cognitive dysfunction (140, 141, 144148)